Clinical Trial Update: Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating rituximab in combination with fludarabine for Waldenström's macroglobulinemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Waldenström Macroglobulinemia

Drugs mentioned

• Fludarabine (Fludarabine)
• Rituximab (rituximab)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Lymphoma | Phase 2 | Status: COMPLETED